Engineering a suite of E. coli strains for enhanced expression of bacterial polysaccharides and glycoconjugate vaccines. (2022)

First Author: Kay EJ
Attributed to:  Development, production and testing of novel glycoconjugate pig vaccines funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12934-022-01792-7

PubMed Identifier: 35449016

Publication URI: http://europepmc.org/abstract/MED/35449016

Type: Journal Article/Review

Volume: 21

Parent Publication: Microbial cell factories

Issue: 1

ISSN: 1475-2859